Sex differences in [123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

Synapse

Volumn 41, Issue 4, 2001, Pages 275-284

  Staley, Julie K ^a,b   Krishnan Sarin, Suchitra ^a   Zoghbi, Sami ^a   Tamagnan, Gilles ^a   Fujita, Masahiro ^a   Seibyl, John P ^a   Maciejewski, Paul K ^a   O'Malley, Stephanie ^a   Innis, Robert B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Brain; Female; Male; Nicotine; Reuptake; Single photon emission computed tomography

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE; IODINE 123; NICOTINE; SEROTONIN; TROPANE DERIVATIVE; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DOPAMINE TRANSPORTER; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN STEM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIENCEPHALON; FEMALE; HOMEOSTASIS; HUMAN; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; STRIATE CORTEX; AFFECT; COMPARATIVE STUDY; CORPUS STRIATUM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SCINTISCANNING; SEXUAL DEVELOPMENT;

ADULT; AFFECT; BRAIN STEM; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; RADIOPHARMACEUTICALS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS; SMOKING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035883173     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1084     Document Type: Article

References (66)

1. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: Basic findings from the national comorbidity survey
2. The importance of measuring cotinine levels to identify smokers in clinical trials
3. A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD
4. 3H]paroxetine binding to serotonin uptake sites in human brain tissue
5. 123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI
6. Influence of nicotine on the release of monoamines in the brain
7. Effects of nicotine administration on the uptake and biosynthesis of 5-HT in rat brain synaptosomes
8. 125I] RTI-55: A potent ligand for dopamine transporters
9. 125I]RTI-55 to dopamine and serotonin transporters in rat brain
10. 123I]β-CIT and SPECT: Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy
11. Distribution of nicotinic subtypes in human brain
12. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use
13. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking
14. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers
15. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex
16. Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research
17. Nicotine dependence in women
18. Inhibition of monoamine oxidase in the brains of smokers
19. Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase B (MAO B) inhibition
20. On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons
21. Evaluation of ultrafiltration for the free fraction determination of single photon emission computed tomography (SPECT) tracers: β-CIT, IBF, and iomazenil
22. Smoking cessation and gender: The influence of physiological, psychological, and behavioral factors
23. Neurobehavioral and health-related deficits in solvent-exposed painters
24. Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo-controlled study
25. The regional distribution of dopamine and serotonin uptake and transmitter concentrations in human brain
26. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire
27. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the US population
28. Plasma cotinine: Stability in smokers and validation of self-reported smoke exposure in nonsmokers
29. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates
30. Regional distribution of serotonergic pre- and postsynaptic markers in human brain
31. 3H]paroxetine binding, a marker of serotonin uptake sites
32. 123I]β-CIT binding to dopamine transporters in healthy human subjects
33. 123I] FPCIT SPET in healthy volunteers
34. The factor structure of the profile of mood states (POMS) and its relationship to occupational lead exposure
35. 123I]β-CIT SPECT
36. 3H]-paroxetine binding to human platelets
37. Oestradiol-17β increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain
38. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT binding sites in female rat brain
39. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids
40. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke
41. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
42. Effect of chronic estradiol and progesterone treatments on ovarectimized rats on brain dopamine uptake sites
43. Sex and estrous cycle variations of rat striatal dopamine uptake sites
44. Polymorphism in serotonin transporter gene associated with susceptibility to major depression
45. Accurate three-dimensional registration of CT, PET, and/or MR image of the brain
46. Common aspects of the action of nicotine and other drugs of abuse
47. β-CIT SPECT demonstrates blockade of 5-HT-uptake site by citalopram in the human brain in vivo
48. Reliability of the fagerstrom tolerance questionnaire and the fagerstrom test for nicotine dependence
49. Effects of nicotine on the nucleus accumbens and similarity to those addictive drugs
50. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging
51. Effect of nicotine on human blood platelet serotonin uptake and efflux
52. Effects of systemic nicotine on serotonin release in rat brain
53. Brain dopamine transporter: Gender differences and effect of chronic haloperidol
54. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression
55. High levels of dopamine activity in the basal ganglia of cigarette smokers
56. Mechanism of the release of amines by nicotine
57. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease
58. The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description
59. 125I] RTI-55
60. Multivariate analysis of variance and covariance
61. The development and initial validation of a questionnaire of smoking urges
62. Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT
63. 123I]β-CIT SPECT
64. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors
65. 123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder